IMC Chicago’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$627K Buy
+6,736
New +$597K ﹤0.01% 3782
2025
Q2
Sell
-11,308
Closed -$645K 3267
2025
Q1
$562K Buy
+11,308
New +$715K ﹤0.01% 2590

Other funds holding ACLS

IMC Chicago's ACLS Position: Q1 2026 in Review

IMC Chicago opened a new position in Axcelis (ACLS) in Q1 2026: 6,736 shares worth $627K. The stake represents ﹤0.01% of the portfolio and ranks #3782 among its holdings. This is a return to the name: IMC Chicago previously reported a position in ACLS as recently as Q1 2025.

IMC Chicago first reported a position in ACLS in Q1 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • IMC Chicago held 6,736 shares of Axcelis worth $627K as of Q1 2026.
  • Axcelis was a new IMC Chicago position in Q1 2026.
  • Axcelis made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3782 holding.
  • IMC Chicago first reported a position in Axcelis in Q1 2025 and has held it in 2 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.